Associated Papers
Enabling whole genome sequencing analysis from FFPE specimens in clinical oncology.
Domenico D et al.
Nature Communications, 2025
41309586 (PubMed )
Supplement: 41467_2025_65654_MOESM3_ESM.xlsx › Supplementary_Data_17
Clinical and genomic features of Lynch syndrome differ by tumor site and disease spectrum.
Li S et al.
Nature Communications, 2025
41261115 (PubMed )
Supplement: 41467_2025_65164_MOESM6_ESM.xlsx › Figure_3A
Novel Findings in Pediatric and Adolescent Patients With Cancer and a Germline SMARCA4 Variant.
van Engelen N et al.
Pediatric Blood & Cancer, 2025
40580017 (PubMed )
Supplement: supplement_1.docx
A long-term glioblastoma survivor with Lynch syndrome: a case report of tumor molecular and microenvironment characterization.
Zhou Y et al.
Discover Oncology, 2025
40768092 (PubMed )
Supplement: 12672_2025_3361_MOESM1_ESM.xlsx › somatic
Systematic characterization of BAF mutations provides insights into intracomplex synthetic lethalities in human cancers.
Schick S et al.
Nature Genetics, 2019
31427792 (PubMed )
Supplement: EMS83287-supplement-Supplementary_Table_1.xlsx › cell_lines
An In-Depth Look at Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT): Clinical Implications from Recent Molecular Findings.
Lu B et al.
Journal of Cancer, 2019
SMARCA4-mutated atypical teratoid/rhabdoid tumors are associated with inherited germline alterations and poor prognosis.
Hasselblatt M et al.
Acta Neuropathologica, 2014
Familial rhabdoid tumour 'avant la lettre'--from pathology review to exome sequencing and back again.
Witkowski L et al.
The Journal of Pathology, 2013
Select a paper to view details